AKZA — Akzo Nobel NV Balance Sheet
0.000.00%
- €9.72bn
- €13.96bn
- €10.71bn
- 74
- 39
- 26
- 40
Annual balance sheet for Akzo Nobel NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,842 | 1,196 | 1,775 | 1,718 | 1,448 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,019 | 2,451 | 2,557 | 2,578 | 2,606 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,064 | 5,348 | 6,244 | 6,044 | 5,836 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,945 | 2,104 | 2,259 | 2,296 | 2,440 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 13,177 | 13,878 | 14,741 | 14,558 | 14,249 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,093 | 4,869 | 5,746 | 5,706 | 4,730 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 7,431 | 8,453 | 10,408 | 10,236 | 9,675 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5,746 | 5,425 | 4,333 | 4,322 | 4,574 |
| Total Liabilities & Shareholders' Equity | 13,177 | 13,878 | 14,741 | 14,558 | 14,249 |
| Total Common Shares Outstanding |